Priority will be given to projects carried out in four specific areas: oncology, neuroscience, infectious and cardiovascular diseases. There will also be a fifth area, which will allow for support to cross-cutting biomedical projects.
A rigorous selection process will be carried out in accordance with the highest standards of quality, impartiality, objectivity and transparency.
The process will also follow the recommendations of the European Science Foundation, among other organisations.
It will consist of an initial peer review phase to shortlist projects and a second selection phase to be carried out by committees comprising relevant international experts for each of the research areas.